Sònia Paytubi holds a Biology degree and a PhD in Microbiology from the University of Barcelona (UB). She obtained her PhD degree on the field of gene expression regulation in enteric bacteria. After finishing her PhD she moved to the University of Dundee (UK) where she started her postdoctoral stage studying translation regulation in eukaryotes. Later on, she started a second postdoctoral stage at the University of St Andrews (UK), where she acquired a valuable experience on molecular biology of Archaea. In 2009, she moved back to the UB to focus on the study of chromosomal and plasmid-encoded global modulators in enteric bacteria. In 2018 she joined the Cancer Epidemiology Research Programme (PREC) at the Catalan Institute of Oncology (ICO). Her current interest is identifying molecular biomarkers for HPV-related cancer screening. She is Co-PI of ELAVImet, a project awarded Institute of Health Carlos III (ISCIII) (PI20/01836) where she investigates novel human and viral biomarkers to detect anal high-grade intraepithelial lesions among MSM living with HIV. She is also focused on evaluating, through NGS and other state-of-the-art techniques, the genomic alterations in minimally invasive samples from patients with high risk of developing endometrial and ovarian cancer.